Financial Ratios

SOCRUS BIO SCIENCES LTD.

NSE : NABSE : 524719ISIN CODE : INE858A01039Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.480 (0 %)
PREV CLOSE ( ) 0.48
OPEN PRICE ( ) 0.49
BID PRICE (QTY) 0.48 (600)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 300
TODAY'S LOW / HIGH ( )0.48 0.49
52 WK LOW / HIGH ( ) 0.480.49
NSE
This Company is not listed in NSE
Select year
ParticularsMar2013Mar2012Mar2011Mar2009Mar2008
Operational & Financial Ratios
   Earnings Per Share (Rs)-12.301.601.440.050.16
   CEPS(Rs)-10.951.621.460.090.20
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.4012.7011.108.118.09
   Tax Rate(%)0.0020.66-8.898.30-1088.92
Margin Ratios
   Core EBITDA Margin(%)-176.2021.4418.90-2.24-6.84
   EBIT Margin(%)-197.9221.4119.232.957.98
   Pre Tax Margin(%)-197.9221.4019.231.360.37
   PAT Margin (%)-197.9216.9820.941.244.42
   Cash Profit Margin (%)-176.2117.1421.232.385.63
Performance Ratios
   ROA(%)-188.8713.9120.980.160.30
   ROE(%)-187.8413.4519.510.602.00
   ROCE(%)-187.8316.9617.920.360.53
   Asset Turnover(x)0.950.821.000.130.07
   Sales/Fixed Asset(x)1.421.271.743.533.29
   Working Capital/Sales(x)69.301.902.360.590.07
Efficiency Ratios
   Fixed Capital/Sales(x)0.710.790.570.280.30
   Receivable days0.0073.5850.1040.7238.00
   Inventory Days63.9449.4368.86398.95438.28
   Payable days5.600.720.430.376.63
Valuation Parameters
   PER(x)0.003.113.1942.4331.17
   PCE(x)-0.113.083.1522.1624.44
   Price/Book(x)2.960.390.420.250.62
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.190.530.660.5214.52
   EV/Core EBITDA(x)-0.112.443.4012.81157.89
   EV/EBIT(x)-0.102.453.4517.74181.96
   EV/CE(x)2.330.400.440.280.96
   M Cap / Sales0.190.530.670.531.38
Growth Ratio
   Net Sales Growth(%)-34.0636.60287.617.00-44.03
   Core EBITDA Growth(%)-638.5750.941751.28-52.43-10.67
   EBIT Growth(%)-709.5852.082425.80-60.42150.61
   PAT Growth(%)-868.5910.796430.15-69.89122.13
   EPS Growth(%)-868.5910.792889.88-69.89122.13
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.005.91
   Current Ratio(x)1.30265.58237.89292.372736.60
   Quick Ratio(x)0.36164.53184.68105.802522.80
   Interest Cover(x)0.003204.495461.501.851.05
   Total Debt/Mcap(x)0.000.000.000.009.56

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.